BEAMBeam Therapeutics Inc.

$26.83
Latest close: below its 200-day averageSep 8, 2026what changed →

What is the market doing?

What the tape says about BEAM

Beam Therapeutics Inc. is +57% over the past year while the S&P 500 is +20%: 37 points ahead of the market.

+57%

1-year return · S&P 500 +20%

vs 200-day average
−3.8%

vs 200-day average · below trend, but not far

RSI (14)
49

RSI (14) · neutral

Below its 52-week high
24%

Below its 52-week high

2024-08-15$14.54 – $35.53 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$26.83
1 monthS&P 500 −0.30%
−1.5%
1 yearS&P 500 +20%
+57%
5 yearsS&P 500 +85%
−75%
vs 50-day average$29.02
−7.5%
52-week high
$35.53
52-week low
$16.01
Annualised volatility
74%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$10M
Calendar-year price return
YearReturn
2026 (year to date)−3.2%
2025+12%
2024−8.9%
2023−30%
2022−51%
2021−2.4%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan63 of 6+1.6%
Feb64 of 6+11%
Mar70 of 7−20%
Apr74 of 7−7.1%
May74 of 7+7.6%
Jun76 of 7+13%
Jul73 of 7+4.0%
Aug73 of 7−1.2%
Sep72 of 7−0.16%
Oct63 of 6+2.3%
Nov65 of 6+17%
Dec63 of 6+7.6%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.